effectiveness of glp-1 Q&A: Long-term success therapies hinges on more than just a prescription Comparison of approved GLP-1 RAs

The Reality of Muscle Loss on Anti-Obesity Medications: What the Data Actually Shows When you lose 30, 50, or 100 pounds, you are not just losing fatyou are also shedding lean mass

Heart failure with preserved ejection fraction (HFpEF) is the most common form of HF, especially among people with obesity

Trulicity offers a simple, once-weekly way to control type 2 diabetes and prevent cardiovascular disease (CVD) or help with existing CVD

Improved clinician awareness, adverse-event reporting, product-quality monitoring, digital risk communication, and proportionate regulatory oversight are needed to distinguish evidence-based peptide therapy from unregulated consumer use.

Discover what that means for Ozempic, Wegovy, and overall GLP-1 results.